Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors. RNA modification has ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...

Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases. The ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...

CHARLOTTE, NC, UNITED STATES, November 19, 2025 /EINPresswire.com/ -- Lobby AI, a leading finance-trained AI platform built specifically for CRE, today announced a ...

The Federal Reserve’s 3Q25 Senior Loan Officer Opinion Survey showed unchanged lending standards and the first increase in CRE loan demand since 1Q22. This marks a notable shift in the CRE market ...

Office space demand weak despite return-to-office mandates Lenders extend loans, but hawkish Fed may upset plans Forecast for loan-loss provisions to rise in 2026 Nov 6 (Reuters) - U.S. regional banks ...

The mRNA COVID-19 vaccines might make some cancer treatments more effective. Lung cancer patients who received the vaccine within a few months of immunotherapy, which revs up the immune system, lived ...

COVID-19 mRNA vaccines create enough of an immunity boost to extend survival in certain types of lung and skin cancers, an analysis of more than 1,000 patient files showed. The scientific journal ...

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...

Institutional investors are pressing pause on some commercial real estate acquisitions, new survey data shows. Institutions cut their target allocations for real estate for 2025 compared to the prior ...